Aqueous ophthalmic formulations

摘要

The present invention relates to aqueous ophthalmic formulations containing cyclosporine and methods for treating and/or preventing ophthalmic diseases or disorders of humans or animals. The present ophthalmic formulations and methods are highly suitable for ocular administration, more particularly administration in the front of the eye, and provide therapeutic effects to the eye as they are effective in stabilizing, enhancing and/or improving a patient's vision. More specifically, the present invention relates to ophthalmic formulations and methods for preventing and/or treating ophthalmic diseases or disorders directly and/or indirectly related to inflammatory conditions.